Response of CD30+ large cell lymphoma of skin to bexarotene

Leukemia and Lymphoma

Volumn 43, Issue 5, 2002, Pages 1153-1154

  Keung, Yi Kong ^a   Woodruff, Ralph ^b   Sangueza, Omar ^b  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Bexarotene; CD30+; Cutaneous lymphoma; Mycosis fungoides

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; BEXAROTENE; CD30 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; PREDNISONE; WARFARIN;

AGED; ARTICLE; BACTERIAL PNEUMONIA; CANCER CLASSIFICATION; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; ELECTRON BEAM; EPIDERMIS; FEMALE; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LUNG EMBOLISM; LYMPHOCYTIC INFILTRATION; LYMPHOID CELL; MYCOSIS FUNGOIDES; PATHOLOGY; PRIORITY JOURNAL; SKIN BIOPSY; SKIN LYMPHOMA;

AGED; AGED, 80 AND OVER; ANTIGENS, CD30; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL; MYCOSIS FUNGOIDES; SKIN NEOPLASMS; TETRAHYDRONAPHTHALENES;

EID: 0036239086     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190290021425     Document Type: Article

References (5)

1. "A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group"
2. "Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sezary syndrome The French Study Group on Cutaneous Lymphomas"
3. "Transformation of mycosis fungoides: Clinicopathological and prognostic features of 45 cases French Study Group of Cutaneous Lymphomas"
4. "Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: Multinational phase II-III trial results"
5. "Mycosis fungoides with CD30-positive cells in the epidermis"